Status:
COMPLETED
PICTURE Breast XS: Patient Information Combined for Local Therapy oUtcome Assessment in bREast Cancer - Cross-sectional
Lead Sponsor:
University College, London
Collaborating Sponsors:
European Union
Conditions:
Early-Stage Breast Carcinoma
Eligibility:
FEMALE
18+ years
Brief Summary
This project which is fully funded by the European Union FP7 Program is designed to pull together all the information we obtain from scans and x-rays to design a personalised 3-D digital model of each...
Detailed Description
Breast cancer is the most common cancer to affect women in Europe, having a lifetime risk of 1 in 9. It is an increasingly treatable disease, and 10-year survival now exceeds 80%. The primary treatmen...
Eligibility Criteria
Inclusion
- Women who have undergone breast conserving surgery for early breast cancer more than one year ago.
- Written informed consent obtained.
Exclusion
- Unable to provide written informed consent.
- Younger than 18 years.
- Benign breast disease.
- Women who have had a mastectomy.
Key Trial Info
Start Date :
March 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
222 Patients enrolled
Trial Details
Trial ID
NCT02310984
Start Date
March 1 2014
End Date
December 1 2016
Last Update
March 17 2017
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Leiden University Medical Center (LUMC)
Leiden, Netherlands
2
Champalimaud Cancer Center
Lisbon, Portugal
3
Royal Free Hospital
London, United Kingdom, NW3 2QG